This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
New DM programmes for US company. Pharmacoecon. Outcomes News 365, 4 (2002). https://doi.org/10.1007/BF03279139
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279139